Related Experiment Video

Updated: Sep 26, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Role of ACE inhibitors in treating hypertensive diabetic patients

Dmitri Kirpichnikov1, James R Sowers

  • 1Department of Endocrinology, Diabetes and Hypertension, SUNY Health Science Center at Brooklyn, 450 Clarkson Avenue, Box 1205, Brooklyn, NY 11203, USA.

Current Diabetes Reports
|March 20, 2003
PubMed

Insights

Angiotensin-converting enzyme (ACE) inhibitors can reduce cardiovascular disease (CVD) in patients with type 2 diabetes and hypertension. This therapy may also improve insulin resistance and prevent type 2 diabetes development.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Cardiovascular disease (CVD) is a leading cause of death in type 2 diabetes patients.
  • Hypertension is present in over 70% of diabetes cases, increasing CVD risk.
  • The renin-angiotensin system (RAS) plays a role in hypertension and insulin resistance.

Purpose of the Study:

  • To explore the mechanisms by which ACE inhibitors improve cardiovascular outcomes in hypertensive diabetic patients.
  • To investigate the effects of ACE inhibitors on insulin resistance, coagulation, and vascular function.
  • To assess the potential of ACE inhibitors in preventing type 2 diabetes in hypertensive individuals.

Main Methods:

  • Review of clinical trial data comparing ACE inhibitors with other antihypertensive medications.
  • Analysis of mechanisms underlying ACE inhibition's effects on metabolic and vascular parameters.
  • Summary of evidence regarding ACE inhibitors' impact on CVD morbidity and mortality in diabetic populations.

Main Results:

  • ACE inhibitors demonstrate superior efficacy over other antihypertensives in reducing CVD events in hypertensive diabetics.
  • ACE inhibition may improve insulin sensitivity and vascular function.
  • Evidence suggests ACE inhibitors could postpone or prevent type 2 diabetes onset.

Conclusions:

  • ACE inhibitor therapy is a valuable strategy for managing cardiovascular risk in hypertensive patients with type 2 diabetes.
  • Understanding the multifaceted benefits of ACE inhibitors can guide treatment decisions.
  • Further research into ACE inhibition's role in diabetes prevention is warranted.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...